Macquarie Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Macquarie Group’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-102,694	Closed	-$969K	–	1696
2023 Q3	$969K	Buy	102,694 +2,003	+2%	+$24.1K	﹤0.01%	1344
2023 Q2	$1.41M	Buy	100,691 +15,380	+18%	+$262K	﹤0.01%	1280
2023 Q1	$1.6M	Sell	85,311 -1,029	-1%	-$16.9K	﹤0.01%	1232
2022 Q4	$1.19M	Sell	86,340 -26,847	-24%	-$411K	﹤0.01%	1367
2022 Q3	$2.18M	Sell	113,187 -995	-0.9%	-$18.1K	﹤0.01%	1198
2022 Q2	$1.74M	Buy	114,182 +552	+0.5%	+$8.16K	﹤0.01%	1342
2022 Q1	$2.31K	Buy	113,630 +3,577	+3%	+$72.8K	﹤0.01%	1329
2021 Q4	$3.21M	Buy	110,053 +2,730	+3%	+$78.1K	﹤0.01%	1237
2021 Q3	$2.31M	Buy	107,323 +48,371	+82%	+$1.17M	﹤0.01%	1338
2021 Q2	$1.51M	Buy	+58,952	New	+$1.26M	﹤0.01%	1500

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Macquarie Group's CDMO Position: Q4 2023 in Review

Macquarie Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 102,694 shares — an estimated $969K sold.

Macquarie Group first reported a position in CDMO in Q2 2021 and held it in 10 quarters. The position peaked at $3.21M in Q4 2021. 174 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

Macquarie Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Macquarie Group sold 102,694 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $969K.
Macquarie Group first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Macquarie Group's Avid Bioservices, Inc. Common Stock position peaked at $3.21M in Q4 2021.
174 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Macquarie Group's 13F filing for Q4 2023, filed 14 Feb 2024.